Th1
[대역어] Th1
[용어속성] Protein
[용어속성] Protein
Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
Medicine
[키워드] acute respiratory syndrome
adaptive
Adaptive immune response
Admission
Asymptomatic
carried
caused
Complication
complications
coronavirus
Coronavirus disease 2019
correlated
Course
COVID-19
COVID-19 patient
COVID-19 patients
cytokine level
cytokine levels
Cytokine storm
Cytokines
described
develop
disease severity
Exhaustion
Follow-up
form
functional
healthy subjects
highlight
hospital
Hospitalization
identify
IFN
IFNs
IFNα
IFNγ
IFNγ level
IL1β
IL6
IL8
Immune cell
immune cells
immune factor
immunological profile
immunology
in vitro
independent
Infectious diseases
Inflammatory
Inflammatory cytokine
interferon
majority
Mild
moderate
multivariable analysis
non-specific
observation
outcome
Patient
Personalized medicine
plasma
Potential biomarker
pro-inflammatory cytokine
Production
Prospective Study
reduced
remained
restored
SARS-CoV-2
secretion
severe COVID-19 patient
significantly increased
Spread
Th1
the disease
the WHO
TNFα
Treatment
Type
type I
type II IFN
type II interferon
were measured
Wuhan
[DOI] 10.3389/fmed.2020.603961 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2020.603961 PMC 바로가기 [Article Type] Medicine
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques
SARS-CoV-2는 붉은 털 원숭이에서 강력한 생식 중심 CD4 T 여포 도우미 세포 반응을 유도합니다
Article
[키워드] Adaptive immunity
Antibody Response
Antibody responses
Antiviral
Blood
CD4
Cell
convalescent plasma
COVID-19
follicular
GC response
GC responses
generate
Germinal center
helper cell
humoral
induce
induction
Infectious diseases
infused
infusion
lung
lymph nodes
Mild
Monocytes
Nucleocapsid proteins
Peripheral blood
plasma
pro-inflammatory monocyte
pro-inflammatory monocytes
question
receiving
response
rhesus
rhesus macaque
rhesus macaques
robust
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 spike
serum IgG antibodies
skewed
stimulate
Tfh
Tfh cell
Th1
the SARS-CoV-2
Viral
viral infections
Viral proteins
[DOI] 10.1038/s41467-020-20642-x PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-020-20642-x PMC 바로가기 [Article Type] Article
K18-hACE2 mice develop respiratory disease resembling severe COVID-19
K18-hACE2 쥐, 심각한 COVID-19와 유사한 호흡기 질환 발병
Research Article
[키워드] angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
animal model
animal models
Asymptomatic
Author
both groups
Brain
cerebral cortex
chemokines
clinical manifestation
Course
COVID-19
COVID-19 pandemic
COVID-19 pathogenesis
cytokeratin 18 promoter
develop
disease
disease course
disease manifestation
dose-dependent
DPI
etiological agent
expressing
Extrapulmonary
hACE2
hippocampus
Human
human SARS-CoV-2
humanized
immunological disease
immunological diseases
in both group
Infection
infectious virus titer
inoculated
inoculation
interstitial pneumonia
intestinal tract
K18
K18-hACE2 mice
lethal disease
low dose
Lower respiratory tract
lung
Lungs
lymphocyte
lymphocyte infiltration
Macrophage
mice
Mild
mild to moderate
moderate disease
nasal turbinates
Pathogenesis
pathology
patients
Pneumocytes
post inoculation
progression
proinflammatory
Pulmonary pathology
rapid inflammatory response
receptor
replication of SARS-CoV-2
reported
respiratory
Respiratory disease
respiratory tract infection
resulting
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 replication
Severe case
severe cases
severe COVID-19
subset
Support
survival
susceptible
TCID
Th1
Th1 and proinflammatory cytokines/chemokines
the SARS-CoV-2
These data
Trachea
transgenic mice
upper and lower respiratory tract
upper and lower respiratory tract infection
upregulation
Viral
Viral RNA shedding
virus replication
virus titers
weight loss
while
[DOI] 10.1371/journal.ppat.1009195 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.ppat.1009195 PMC 바로가기 [Article Type] Research Article
Recombinant protein vaccines, a proven approach against coronavirus pandemics
Review
[키워드] aa, amino acid
ACE-2, Angiotensin-converting enzyme 2
ADE, Antibody-dependent enhancement
adjuvants
Alum, Aluminum hydroxide
APC, Antigen-Presenting Cell
cGMP, Current good manufacturing practices
clinical trials
CoV, coronavirus
COVID-19
COVID, Coronavirus disease 2019
FDA, US Federal Drug Administration
HHS, US Department of Health and Human Services
MERS, Middle East respiratory syndrome
MNA, Micro-needle array
Neutralizing antibodies
NTD, N-terminal domain
OWS, Operation Warp Speed
PTM, post-translational modification
RBD, receptor binding domain
RBM, receptor binding motif
RSV, respiratory syncytial virus
S-protein, Spike protein (S1/S2)
SARS-CoV-2
SARS, Severe acute respiratory syndrome
Th1
TMPRSS2, Transmembrane Protease Serine 2
vaccine delivery
vaccine production
WHO, World Health Organization
[DOI] 10.1016/j.addr.2021.01.001 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.addr.2021.01.001 PMC 바로가기 [Article Type] Review
Cytokine profile and disease severity in patients with COVID-19
COVID-19 환자의 사이토카인 프로필 및 질병 중증도
Article
[키워드] (enzyme-linked immunosorbent assay
age
All participants
Analysis
ANOVA
both groups
can be used
collected
Concentration
conducted
control group
controls
coronavirus disease
Coronavirus disease 2019
correlated
COVID-19
COVID-19 patient
COVID-19 patients
cytokine
Cytokine dysregulation
cytokine level
cytokine levels
Cytokines
disease severity
dysregulation
ELISA
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
evaluate
healthy subject
IFN-γ
IL-17
IL-5
IL-8
IL-9
in both group
infected with SARS-CoV-2
interferon
interferon-γ
interleukin
involved
mechanism
Mild
not differ
one-way ANOVA
participant
Patient
patients
patients with COVID-19
Predictive
proinflammatory
responses
serum
Serum level
serum levels
serum sample
serum samples
severe group
severity
significant difference
significant differences
significantly
significantly higher
statistical analysis
systemic
tested
TGF-β
Th1
Th17
Treg
was performed
[DOI] 10.1016/j.cyto.2020.155323 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.cyto.2020.155323 PMC 바로가기 [Article Type] Article
Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus
Review
[키워드] ACE2
acute respiratory syndrome
affected
aggravate
angiotensin-converting enzyme 2
anti-inflammatory effect
Asymptomatic COVID-19
Autoimmune
benefit
binding
caused
Cell
cleavage
clinical trial
coronavirus
Coronavirus disease 2019
COVID-19
COVID-19 progression
cytosolic
Diabetes Mellitus
Dipeptidyl peptidase-4
Effectiveness
Evidence
exhibit
facilitate
furin
global pandemic
glycemic control
glycosylation
Hospitalization
human Angiotensin-converting enzyme
hyperglycemia
immune response
induce
inhibitor
Injury
innate immune system
Innate immunity
Lactate
lower mortality
medication
metabolites
Mild
novel
outcomes
pancreatic
Patient
patients with diabete
pro-inflammatory cytokine
protective effect
Randomized
receptor
reduction in
renin–angiotensin–aldosterone system
S protein
SARS-CoV-2
SARS-COV-2 infection
severe acute respiratory syndrome coronavirus 2
susceptibility
targets
Th1
Th2 immunity
the S protein
TMPRSS2
transmembrane serine protease
Treatment
Trigger
uncontrolled
vicious cycle
viral entry
viral genome
viral S protein
[DOI] 10.3390/jcm9123962 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jcm9123962 PMC 바로가기 [Article Type] Review
Management of immune checkpoint therapy for patients with cancer in the face of COVID-19
코로나19에 직면한 암환자의 면역관문치료 관리
Article
[키워드] administration
adverse effect
Antiviral
assist
Biomarkers
caused
Chronic diseases
clearance
coronavirus
COVID-19
COVID-19 outbreak
death
Decision-making
ENhance
expression
immune
Immune checkpoint inhibitor
Immune checkpoint inhibitors
Immunopathogenesis
immunopathological damage
Immunotherapy
in some
Inflammation
malignant tumor
marker
medical system
MONITOR
pandemic
Pathogenesis
pathogenic
Patient
Patients with cancer
receiving
respiratory
Respiratory disease
respiratory diseases
risk
SARS-CoV-2
subset
T-cell
Th1
Th17
therapy
Treatment
Tumor
Usage
virus
[DOI] 10.1136/jitc-2020-001593 PMC 바로가기 [Article Type] Article
[DOI] 10.1136/jitc-2020-001593 PMC 바로가기 [Article Type] Article
Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset
Immunology
[키워드] Activation
Adaptive immune response
affected
Analysis
Blood
CD38
CD4+
CD8
CD8+
CD8+ T cell
Cell
characterized
clinical
COVID-19
COVID-19 patient
Critical
decrease
donors
effective
explain
Express
Factor
Frequency
Frequently
high-risk population
HLA-DR
immune profiling
Increased
Inflammatory
innate response
lymphocyte
lymphopenia
marker
multiparametric flow cytometry
negative
outcome
Patient
performed
Peripheral blood
SARS-COV-2 infection
severe acute respiratory syndrome coronavirus 2
severe coronavirus disease 2019
severity
Strong
subset
T cell
T cell response
T cells
T cells response
T helper
T lymphocyte
T-CD8 lymphocytes flow cytometric immunophenotyping
Th cell
Th lymphocytes
Th1
Th1 cell
Th1/Th17
Th17
Undifferentiated
virus infection
virus load
[DOI] 10.3389/fimmu.2020.596553 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2020.596553 PMC 바로가기 [Article Type] Immunology